Site Search

EN
CN EN
National unified service hotline

National unified service hotline

153 5610 0737

BRSM

China’s First Preclinical CRO Specializing in Respiratory Drug Development
with Expertise in Inhalation Formulations

BRSM originated from the Zhejiang University Respiratory Drug Research Laboratory team, formerly affiliated with China’s National Medical Products Administration (NMPA). Our expert team includes:

· National respiratory pharmacology evaluation experts specializing in novel drugs

· Former BD Head of WuXi AppTec North America

· Pioneers in China’s inhalation drug R&D

· Ph.D. scientists from top global institutions

As the earliest team in China to conduct preclinical biological evaluations for inhalation drugs, we bring deep expertise in respiratory pharmacology and immunopharmacology. 

More

Technical Services

  • Pharmacodynamic Evaluation

    Led by experts with extensive experience in NMPA new drug reviews, our team consists of highly qualified professionals who have extensive expertise in biological evaluation. We strictly comply with NMPA's Good Laboratory Practice (GLP) regulations, maintaining over 100 animal/cell models and 300+ SOPs to ensure a robust and standardized evaluation system.
    More>

  • Pharmacokinetic Evaluation

    Our high-throughput, high-sensitivity, and scalable PK research and detection platform is supported by a team with decades of PK study experience. We emphasize scientific rigor in experimentation and result interpretation, with a strong focus on applying PK findings to specific drug development programs.
    More>

  • Non-Clinical Safety Evaluation

    In collaboration with experienced GLP-certified safety evaluation centers and under the guidance of CDE drug review experts, we conduct specialized toxicology evaluations for inhalation preparations and nasal sprays. Our approach combines regulatory expertise with practical application in novel drug development.
    More>
  • Pharmacodynamic Evaluation
  • Pharmacokinetic Evaluation
  • Non-Clinical Safety Evaluation
BRSM Laboratories

BRSM Laboratories

With 1,000 m² of functional laboratories and 500 m²of SPF-grade animal housing facilities, we provide comprehensive preclinical research capabilities.

Our integrated preclinical evaluation platforms include: Experimental Animal Research, Pharmacodynamic Evaluation, Non-Clinical Safety Assessment, Pharmacokinetics (PK) Studies, Pathophysiological Evaluation


Certifications & Honors

To date, our preclinical evaluations have supported 11 drug approvals for production，20+ clinical trial approvals (CTAs)，including 5 Category 1 innovative chemical drugs and 5 Category 1 biologics."

Hangzhou "Eaglet Plan" Enterprise Certification

National High-Tech Enterprise Certification

Laboratory Animal Use License

Zhejiang Provincial Sci-Tech SME Certification

#
Live Chat

x